MLL
NVO

Moody Lynn & Lieberson’s Novo Nordisk NVO Stock Holding History

Moody Lynn & Lieberson’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,353
Closed -$1.15M – 253
2024
Q4 		$1.15M Sell
13,353
-400
-3% -$43.3K 0.07% 107
2024
Q3 		$1.64M Sell
13,753
-51,287
-79% -$6.84M 0.1% 98
2024
Q2 		$9.28M Buy
65,040
+100
+0.2% +$13.3K 0.61% 38
2024
Q1 		$8.34M Sell
64,940
-360
-0.6% -$42.9K 0.56% 39
2023
Q4 		$6.76M Sell
65,300
-20
-0% -$1.98K 0.51% 44
2023
Q3 		$5.94M Sell
65,320
-6,050
-8% -$533K 0.51% 44
2023
Q2 		$5.77M Sell
71,370
-1,560
-2% -$127K 0.47% 50
2023
Q1 		$5.8M Sell
72,930
-50
-0.1% -$3.55K 0.52% 47
2022
Q4 		$4.94M Buy
+72,980
New +$4.28M 0.45% 46
2016
Q3 		– Sell
-8,800
Closed -$237K – 178
2016
Q2 		$237K Hold
8,800
– – 0.04% 145
2016
Q1 		$238K Hold
8,800
– – 0.04% 150
2015
Q4 		$256K Sell
8,800
-147,600
-94% -$4.09M 0.04% 156
2015
Q3 		$4.24M Buy
156,400
+147,600
+1,677% +$4.18M 0.81% 49
2015
Q2 		$241K Hold
8,800
– – 0.04% 172
2015
Q1 		$235K Buy
+8,800
New +$203K 0.04% 170
2014
Q4 		– Sell
-8,800
Closed -$210K – 201
2014
Q3 		$210K Sell
8,800
-490
-5% -$11.3K 0.03% 180
2014
Q2 		$215K Hold
9,290
– – 0.03% 187
2014
Q1 		$212K Buy
+9,290
New +$198K 0.03% 186
2013
Q4 		– Sell
-48,600
Closed -$822K – 207
2013
Q3 		$822K Buy
48,600
+35,300
+265% +$594K 0.13% 114
2013
Q2 		$206K Buy
+13,300
New +$221K 0.04% 155

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Moody Lynn & Lieberson's NVO Position: Q1 2025 in Review

Moody Lynn & Lieberson sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 13,353 shares — an estimated $1.15M sold.

Moody Lynn & Lieberson first reported a position in NVO in Q2 2013 and held it in 20 quarters. The position peaked at $9.28M in Q2 2024. 1,531 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Moody Lynn & Lieberson reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 13,353 Novo Nordisk shares in Q1 2025, an estimated $1.15M.
  • Moody Lynn & Lieberson first reported a position in Novo Nordisk in Q2 2013 and held it in 20 quarters.
  • Moody Lynn & Lieberson's Novo Nordisk position peaked at $9.28M in Q2 2024.
  • 1,531 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Moody Lynn & Lieberson's 13F filing for Q1 2025, filed 28 Apr 2025.